BTSG BrightSpring Health Services, Inc.
Q3 2025 10-Q
BrightSpring Health Services, Inc. (BTSG) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 28, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ3 2025 10-Q
Management Discussion & Analysis
- • Inflation impacts labor costs, key expense driver, amid labor shortages and growing demand for homecare
- • Pharmacy Solutions drug costs rising, some passed to customers; supply chain inflation mitigated recently
Risk Factors
- • No new or updated risk factors disclosed this quarter versus most recent 10-K
- • Carry-forward legal risk: compliance with Sarbanes-Oxley Act certifications by CEO and CFO included as Exhibits 31.1, 31.2, 32.1, 32.2
Quarterly Financial SummaryXBRL
Revenue
$3.3B
▲ +14.7% YoY▲ +5.9% QoQ
Net Income
$56M
▲ +778.4% YoY▲ +97.9% QoQ
Gross Margin
11.8%
▼ -228bp YoY▼ -15bp QoQ
Operating Margin
2.6%
▲ +68bp YoY▲ +109bp QoQ
Net Margin
1.7%
▲ +196bp YoY▲ +78bp QoQ
ROE
3.1%
Total Assets
$6.0B
EPS (Diluted)
$0.25
▲ +725.0% YoY▲ +92.3% QoQ
Operating Cash Flow
$108M
▲ +296.2% YoY▲ +119.9% QoQ
Source: XBRL data from BrightSpring Health Services, Inc. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on BrightSpring Health Services, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.